David W. Nassif - Interim CEO, CFO, Director at Sio Gene Therapies Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Interim CEO, CFO, Director
Issuer Symbol
SIOX
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by David W. Nassif since 13 Mar 2025

Holdings reported by David W. Nassif for Sio Gene Therapies Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Restricted Stock Units 546,500 08 Feb 2022 Direct Common Stock

Transactions reported by David W. Nassif for Sio Gene Therapies Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.